The MCF-7 cells over-expressing OPG did not show any alteration in sensitivity to TRAIL treatment in vitro, suggesting that there must be additional mechanisms whereby OPG can have a tumor-promoting effect [30]. The gene discussed is TNFRSF11B; the disease is neoplasm.